BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 28190238)

  • 1. Alpha-Synuclein Suppresses Retinoic Acid-Induced Neuronal Differentiation by Targeting the Glycogen Synthase Kinase-3β/β-Catenin Signaling Pathway.
    Kim S; Lim J; Bang Y; Moon J; Kwon MS; Hong JT; Jeon J; Seo H; Choi HJ
    Mol Neurobiol; 2018 Feb; 55(2):1607-1619. PubMed ID: 28190238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estrogen-related receptor gamma regulates dopaminergic neuronal phenotype by activating GSK3β/NFAT signaling in SH-SY5Y cells.
    Lim J; Choi HS; Choi HJ
    J Neurochem; 2015 May; 133(4):544-57. PubMed ID: 25727910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of AKT1/GSK-3β/β-Catenin-TRIM11/Survivin Pathway by Novel GSK-3β Inhibitor Promotes Neuron Cell Survival: Study in Differentiated SH-SY5Y Cells in OGD Model.
    Darshit BS; Ramanathan M
    Mol Neurobiol; 2016 Dec; 53(10):6716-6729. PubMed ID: 26660108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GSK-3β dysregulation contributes to parkinson's-like pathophysiology with associated region-specific phosphorylation and accumulation of tau and α-synuclein.
    Credle JJ; George JL; Wills J; Duka V; Shah K; Lee YC; Rodriguez O; Simkins T; Winter M; Moechars D; Steckler T; Goudreau J; Finkelstein DI; Sidhu A
    Cell Death Differ; 2015 May; 22(5):838-51. PubMed ID: 25394490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of serum concentration in retinoic acid and phorbol ester induced differentiation of SH-SY5Y human neuroblastoma cell line.
    Magalingam KB; Radhakrishnan AK; Somanath SD; Md S; Haleagrahara N
    Mol Biol Rep; 2020 Nov; 47(11):8775-8788. PubMed ID: 33098048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of dopaminergic neuronal phenotypes by the estrogen-related receptor gamma ligand GSK4716 via the activation of CREB signaling.
    Lim J; Kim HI; Choi HJ
    Neurochem Int; 2020 Jun; 136():104726. PubMed ID: 32173553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GSK-3beta inhibition/beta-catenin stabilization in ventral midbrain precursors increases differentiation into dopamine neurons.
    Castelo-Branco G; Rawal N; Arenas E
    J Cell Sci; 2004 Nov; 117(Pt 24):5731-7. PubMed ID: 15522889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroprotective effects of extract of Acanthopanax senticosus harms on SH-SY5Y cells overexpressing wild-type or A53T mutant α-synuclein.
    Li XZ; Zhang SN; Wang KX; Liu HY; Yang ZM; Liu SM; Lu F
    Phytomedicine; 2014 Apr; 21(5):704-11. PubMed ID: 24252343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Unique GSK-3β inhibitor B10 Has a Direct Effect on Aβ, Targets Tau and Metal Dyshomeostasis, and Promotes Neuronal Neurite Outgrowth.
    Shi XL; Yan N; Cui YJ; Liu ZP
    Cells; 2020 Mar; 9(3):. PubMed ID: 32155989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alpha-Synuclein contributes to GSK-3beta-catalyzed Tau phosphorylation in Parkinson's disease models.
    Duka T; Duka V; Joyce JN; Sidhu A
    FASEB J; 2009 Sep; 23(9):2820-30. PubMed ID: 19369384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interference of alpha-synuclein with cAMP/PKA-dependent CREB signaling for tyrosine hydroxylase gene expression in SK-N-BE(2)C cells.
    Kim SS; Moon KR; Choi HJ
    Arch Pharm Res; 2011 May; 34(5):837-45. PubMed ID: 21656370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alpha-synuclein interferes with cAMP/PKA-dependent upregulation of dopamine β-hydroxylase and is associated with abnormal adaptive responses to immobilization stress.
    Kim S; Park JM; Moon J; Choi HJ
    Exp Neurol; 2014 Feb; 252():63-74. PubMed ID: 24252179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in Cell Cycle and Up-Regulation of Neuronal Markers During SH-SY5Y Neurodifferentiation by Retinoic Acid are Mediated by Reactive Species Production and Oxidative Stress.
    Kunzler A; Zeidán-Chuliá F; Gasparotto J; Girardi CS; Klafke K; Petiz LL; Bortolin RC; Rostirolla DC; Zanotto-Filho A; de Bittencourt Pasquali MA; Dickson P; Dunkley P; Moreira JCF; Gelain DP
    Mol Neurobiol; 2017 Nov; 54(9):6903-6916. PubMed ID: 27771902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. α-Synuclein disrupts the anti-inflammatory role of Drd2 via interfering β-arrestin2-TAB1 interaction in astrocytes.
    Du RH; Zhou Y; Xia ML; Lu M; Ding JH; Hu G
    J Neuroinflammation; 2018 Sep; 15(1):258. PubMed ID: 30200997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of Early Life Lead (Pb) Exposure on α-Synuclein, GSK-3β and Caspase-3 Mediated Tauopathy: Implications on Alzheimer's Disease.
    Bihaqi SW; Alansi B; Masoud AM; Mushtaq F; Subaiea GM; Zawia NH
    Curr Alzheimer Res; 2018; 15(12):1114-1122. PubMed ID: 30068273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RNA interference targeting α-synuclein attenuates methamphetamine-induced neurotoxicity in SH-SY5Y cells.
    Chen L; Huang E; Wang H; Qiu P; Liu C
    Brain Res; 2013 Jul; 1521():59-67. PubMed ID: 23688541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Neuroprotective Role of Insulin Against MPP(+) -Induced Parkinson's Disease in Differentiated SH-SY5Y Cells.
    Ramalingam M; Kim SJ
    J Cell Biochem; 2016 Apr; 117(4):917-26. PubMed ID: 26364587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene Expression Profile of NF-κB, Nrf2, Glycolytic, and p53 Pathways During the SH-SY5Y Neuronal Differentiation Mediated by Retinoic Acid.
    de Bittencourt Pasquali MA; de Ramos VM; Albanus RDO; Kunzler A; de Souza LHT; Dalmolin RJS; Gelain DP; Ribeiro L; Carro L; Moreira JCF
    Mol Neurobiol; 2016 Jan; 53(1):423-435. PubMed ID: 25465239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipid metabolism alterations in the neuronal response to A53T α-synuclein and Fe-induced injury.
    Sánchez Campos S; Alza NP; Salvador GA
    Arch Biochem Biophys; 2018 Oct; 655():43-54. PubMed ID: 30098984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytosolic catechols inhibit alpha-synuclein aggregation and facilitate the formation of intracellular soluble oligomeric intermediates.
    Mazzulli JR; Mishizen AJ; Giasson BI; Lynch DR; Thomas SA; Nakashima A; Nagatsu T; Ota A; Ischiropoulos H
    J Neurosci; 2006 Sep; 26(39):10068-78. PubMed ID: 17005870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.